PharmaShots | Incisive News in 3 Shots

Subscribe Now

Sosei Heptares

Sosei Heptares Initiates to Reclaim Ownership GSK4381406 from GSK

Sosei Heptares Initiates to Reclaim Ownership GSK4381406 from GSK

November 24, 2023

Sosei Heptares Receives $3.75M as a Part of its Multi-Target Agreement with Genentech

Sosei Heptares Receives $3.75M as a Part of its Multi-Target Agreement with Genentech

October 31, 2023

Sosei Heptares Partner Pfizer Report the First Patient Dosing of PF-07081532 in the P-II Clinical Trial for the Treatment of Type 2 Diabetes and Obesity

Sosei Heptares Partner Pfizer Report the First Patient Dosing of PF-07081532 in the P-II Clinical Trial for the Treatment of Type...

December 21, 2022

Sosei Heptares Entered into a Research Collaboration and Option to License Agreement with AbbVie for Novel Therapies to Treat Neurological Diseases

Sosei Heptares Entered into a Research Collaboration and Option to License Agreement with AbbVie for Novel Therapies to Treat Neur...

August 2, 2022

PharmaShots Weekly Snapshots (Dec 21-23, 2020)

PharmaShots Weekly Snapshots (Dec 21-23, 2020)

December 24, 2020

Insights+: COVID-19 Healthcare News Monthly Updates - November 2020

Insights+: COVID-19 Healthcare News Monthly Updates - November 2020

November 26, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us